← Back to Search

Orthopedic Implant

Short-Stemmed with Augmented Fixation for Osteoarthritis

N/A
Waitlist Available
Led By Brent A Lanting, MD, FRCSC
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing a first total knee revision surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-2 weeks (baseline exam) to 1 year
Awards & highlights

Study Summary

This trial is investigating whether long-stemmed or short-stemmed implants are better for revision total knee replacement, as well as comparing patient outcomes and costs.

Eligible Conditions
  • Osteoarthritis
  • Total Knee Arthroplasty

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-2 weeks (baseline exam) to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-2 weeks (baseline exam) to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Implant Migration Over Time
Secondary outcome measures
Euro-Quol Group EQ-5D
Inducible displacement of the tibial component
KOOS Knee Survey
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Short-Stemmed with Augmented FixationExperimental Treatment1 Intervention
Participants will receive the Short-Stemmed primary implant with Augmented Fixation during their surgery.
Group II: Long-Stemmed with Hybrid FixationActive Control1 Intervention
Participants will receive the Long-Stemmed revision implant with Hybrid Fixation during their surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Short-Stemmed with Augmented Fixation
2018
N/A
~20

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,416 Total Patients Enrolled
21 Trials studying Osteoarthritis
5,555 Patients Enrolled for Osteoarthritis
Brent A Lanting, MD, FRCSCPrincipal InvestigatorLondon Health Sciences Centre
1 Previous Clinical Trials
96 Total Patients Enrolled

Frequently Asked Questions

~2 spots leftby Apr 2025